Study: GLP-1 Use Starting to Reshape U.S. Food Spending

Rising adoption of GLP-1 drugs may gradually reshape food demand, with potential downstream effects on protein markets and consumer purchasing patterns.

NASHVILLE, Tenn. (RFD NEWS) — Food spending patterns are shifting as use of GLP-1 weight-loss and diabetes medications expands (like Ozempic and Wegovy), with new research showing measurable reductions in grocery and restaurant demand within months of adoption.

A study highlighted by Meat + Poultry Magazine and published in the Journal of Marketing Research found households reduced grocery spending by an average of 5.3% within six months of starting GLP-1 medications, with higher-income households cutting spending by more than 8%.

Researchers from Cornell University analyzed transaction data from roughly 150,000 households tracked by Numerator, comparing GLP-1 users with similar non-users to isolate post-adoption changes. The steepest declines occurred in calorie-dense foods. Spending on savory snacks fell about 10%, with similar pullbacks in sweets, baked goods, cookies, and other indulgent categories. Core grocery items — including meat, eggs, and bread — also declined.

A small number of categories saw gains, led by yogurt, fresh fruit, nutrition bars, and meat snacks. Foodservice spending also softened, particularly at fast-food restaurants and coffee shops.

The study notes that lower food spending persists for at least a year among continued users, though the impact moderates over time. With GLP-1 use rising rapidly, researchers say long-term implications for food manufacturers, retailers, and restaurants could include changes to product mix, portion sizes, and marketing strategies.

Farm-Level Takeaway: Rising GLP-1 adoption may gradually reshape food demand, with potential downstream effects for protein markets and consumer purchasing patterns.
Tony St. James, RFD News Markets Specialist
Related Stories
Merck’s Gary Tiller discusses new virtual fencing technology and how fence-free livestock management could change the way ranchers manage land and cattle.
The USDA’s February WASDE report looms as the CME Ag Economy Barometer shows declining farmer confidence, and more ag industry groups calling for swift policy action.
Danny Munch of the American Farm Bureau joined us to discuss USDA’s latest farm income forecast, revisions to prior estimates, and what the updated data means for farmers heading into 2026.
HHS Secretary Robert Kennedy calls on cattle producers to retain breeding cows while Ivomec receives emergency authorization to prevent New World screwworm.
Policies aimed at ground beef prices may primarily reshape dairy incentives rather than deliver lasting consumer savings.
Ranchbot Monitoring Solutions provides remote water-monitoring technology to help ranchers manage livestock water more efficiently.
The House Agriculture Committee is set to debate a new, “skinny” Farm Bill at the end of February, according to a release from Committee Chairman Rep. Glenn “GT” Thompson.
The fun continues in Nashville next year at CattleCon 2027!
Regulatory uncertainty could slow the growth of fiber and grain hemp unless implementation is delayed.

Tony St. James joined the RFD-TV talent team in August 2024, bringing a wealth of experience and a fresh perspective to RFD-TV and Rural Radio Channel 147 Sirius XM. In addition to his role as Market Specialist (collaborating with Scott “The Cow Guy” Shellady to provide radio and TV audiences with the latest updates on ag commodity markets), he hosts “Rural America Live” and serves as talent for trade shows.

LATEST STORIES BY THIS AUTHOR:

RFD-TV News contributor Roger McOwen covers important topics in ag law and taxation, including FBAR, Read Before Signing, Reporting 4-H Income, and Attorney-Client Privilege.
A five-year-old in Etheridge, Tennessee, lost his life in a grain auger. His mother shares her story to ensure that other farm families do not have to endure that pain. RFD-TV’s own Tammi Arender reports.
The U.S. government will give pharmaceutical company Moderna $176 million for a High-Path Avian Flu vaccine, Reuters reports.